Produktentwicklung, Dossiererstellung und Life Cycle Management

Das regu­la­torische Leis­tungsangebot der Tenta­Con­sult für Human- und Veter­inärarzneimittel bildet den gesamten Produk­tzyklus ab – von der präk­lin­is­chen Entwick­lung bis hin zu Post Market Follow-Ups. Unsere Exper­tise umfasst dabei chemische, biol­o­gische und pflan­zliche Wirk­stoffe und Hilfsstoffe.


Benefit from our exper­tise resulting from numerous autho­ri­sa­tion proce­dures for medi­c­inal prod­ucts with chem­i­cally defined active substances, phytophar­ma­ceu­ti­cals and biolog­i­cals, carried out either in conjunc­tion with our customers or inde­pen­dently on their behalf.

We will prepare the neces­sary appli­ca­tions and dossiers for the clin­ical trial and the marketing autho­ri­sa­tion in CTD format, either in whole or in part. Regard­less of the active substance and mode of admin­is­tra­tion, we will guide you effec­tively through the national or regional autho­ri­sa­tion proce­dure. The current regu­la­tory require­ments and your indi­vidual needs are of course considered.

Veterinary medicinal products

Veteri­nary medi­c­inal prod­ucts are not the same as medi­c­inal prod­ucts for human use: the regu­la­tory frame­work condi­tions and require­ments differ in many aspects.

We can also prepare the entire dossier for veteri­nary medi­c­inal prod­ucts – regard­less of the active substance, mode of admin­is­tra­tion and autho­ri­sa­tion proce­dure – in NTA format and in line with the latest regu­la­tory requirements.

Product development

The effi­cient devel­op­ment of new active substances and prod­ucts needs a regu­la­tory strategy right from the start. We will work with you to develop this regu­la­tory strategy and will accom­pany you through the preclin­ical and clin­ical devel­op­ment, right from the start.

We will create the dossier for your clin­ical inves­ti­ga­tional medi­c­inal product (IMPD, IND) and can even take care of all of the project manage­ment activ­i­ties if you wish.

In addi­tion, we offer you exten­sive analyt­ical and tech­no­log­ical services within the Tentamus group.

Active substances and excipients

No marketing authorisation/​registration of medi­c­inal prod­ucts is issued without submit­ting dossiers on active ingre­di­ents and excip­i­ents. The compe­tent author­i­ties require compre­hen­sive active-ingre­dient docu­men­ta­tion that takes into account the exten­sive national and inter­na­tional regulations.

We have already prepared, updated and eval­u­ated numerous active-ingre­dient dossiers (ASMF, CEP, US-DMF) and dossiers on excip­i­ents (CEP and US-DMF). These include:

  • Chem­ical active substances
  • Biolog­ical active substances
  • Plant extracts/​herbal active substances
  • Excip­i­ents

Unsere Leistungen

CTD-Erstel­lung und Aktualisierung

  • Modul 1 mit den admin­is­tra­tiven Daten entsprechend den regionalen Anforderungen, auch wenn Sie die Einre­ichungen selbst vornehmen
  • Quality overall summary” (QOS, CTD-Modul 2.3) und das entsprechende Modul 3
  • Nonclin­ical overview” und Tabu­lated and written summaries” (CTD-Module 2.4 und 2.6) sowie das entsprechende Modul 4
  • Clin­ical overview” und Tabu­lated and written summaries” (CTD-Module 2.5 und 2.7) sowie das entsprechende Modul 5
  • Unter­lagen für tradi­tionelle Registrierungen, einschließlich der Erstel­lung eines Tradi­tions­beleges für Phytopharmaka

Beantra­gung klin­is­cher Studien

Wir erstellen die nötigten Unter­lagen für die klin­ische Prüfung (IMPD, IB, IND für US-FDA) und reichen den Antrag bei der zuständigen Behörde für Sie ein. Dazu gehören auch Substan­tial Amend­ments“ im Laufe der Studie.

Scien­tific advice

We prepare scien­tific advice discus­sions with the author­i­ties on your behalf. This means: We prepare the neces­sary docu­ments, submit the appli­ca­tions, accom­pany you to the scien­tific advice with the authority and support you during the discus­sions and in the follow-up.

Dossier for multi­na­tional marketing authorisations

We advise how you can best create your dossier for multi­na­tional marketing autho­ri­sa­tions – in terms of the content as well as strategy. We carry out the rele­vant adjust­ments and revi­sions that will make main­taining cross-regional marketing autho­ri­sa­tions signif­i­cantly easier.

Manage­ment of authorisations

We will support you with submit­ting the appli­ca­tion and selecting a suit­able autho­ri­sa­tion proce­dure, as well as throughout the entire autho­ri­sa­tion process, thus ensuring that you can bring your product to market matu­rity quickly and efficiently.

We are familiar with all types of appli­ca­tions (e.g. full appli­ca­tion, generic, hybrid, well-estab­lished use or tradi­tional regis­tra­tion) and have many years of expe­ri­ence with the different types of autho­ri­sa­tion procedures:

Euro­pean autho­ri­sa­tion procedure:

  • National autho­ri­sa­tion procedure
  • Decen­tralised proce­dure (DCP)
  • Mutual recog­ni­tion proce­dure (MRP)
  • Centralised proce­dure (CP)

US autho­ri­sa­tion procedures:

  • New Drug Appli­ca­tion (NDA)
  • Abbre­vi­ated New Drug Appli­ca­tion (ANDA)
  • Biologics License Appli­ca­tion (BLA)

Process and project management

We support you at every stage of the autho­ri­sa­tion process. You decide at which point you would like our support – in parts or as a full package:

  • Strategic consulting
  • Scien­tific advice and regu­la­tory advice discus­sions with the author­i­ties (e.g. pre-submis­sion meeting, pre-NDA meeting)
  • Prepa­ra­tion of the marketing autho­ri­sa­tion dossier
  • Compi­la­tion of admin­is­tra­tive appli­ca­tion docu­ments (Module 1)
  • eCTD prepa­ra­tion – with external partner
  • Submis­sion to the marketing autho­ri­sa­tion authority
  • Inter­ac­tion with the author­i­ties throughout the procedure
  • Processing ques­tions from the author­i­ties (assess­ment reports, defi­ciency letters, statements)
  • Inter­ac­tion with other involved parties such as contract manu­fac­turers, labo­ra­tory service providers


We take care of creating and managing the labelling of your medi­c­inal product – as well as the summary of product char­ac­ter­is­tics and instruc­tions for use – within the context of the autho­ri­sa­tion and life cycle manage­ment, and we ensure compli­ance with the latest regu­la­tory requirements.

Do you wish to include addi­tional patient infor­ma­tion? We’d be happy to make some design suggestions.

Life cycle management

To keep your dossier contin­u­ally up to date we carry out the neces­sary updates, changes and amend­ments, eval­uate them and notify the compe­tent author­i­ties, thus safe­guarding the marketability of your products.

In terms of life cycle manage­ment, we also under­take sub-tasks or complete sets of marketing autho­ri­sa­tions under port­folio manage­ment with all the regu­la­tory, analyt­ical and tech­nical activ­i­ties required once the marketing autho­ri­sa­tion has been issued.

Our life cycle manage­ment service includes:

  • Regular review and update of the marketing autho­ri­sa­tion dossier
  • Prepa­ra­tion, submis­sion and processing of the rele­vant change requests for the compe­tent author­i­ties (e.g. vari­a­tions, including work-sharing proce­dures, change notifications)
  • Plan­ning and imple­men­ta­tion of change control processes
  • Eval­u­a­tion and processing of devi­a­tions in, for example, procure­ment and manufacturing
  • Extensions/​renewal applications
  • Moni­toring and meeting deadlines

Due Dili­gence und Regu­la­tory Compliance

For all the avail­able docu­ments in your devel­op­ment process, we’ll perform gap analyses, for example of:

  • IMPD and IB
  • Reports on non-clin­ical and clin­ical trials
  • Plans and reports on the phys­ical-chem­ical char­ac­ter­i­sa­tion of active substances, produc­tion devel­op­ment, scale-up, stability, compat­i­bility, formu­la­tion devel­op­ment, impu­rity profiles and stability of clin­ical inves­ti­ga­tional medi­c­inal products

We compile the results from the early stage of the devel­op­ment process in regu­la­tion-compliant reports and eval­uate them in terms of their tech­nical suit­ability and regu­la­tory compli­ance. You receive an in-depth, struc­tured analysis that enables you to close any gaps iden­ti­fied and to create an action plan.

The review of regu­la­tory docu­ments also plays an impor­tant role in the context of licensing nego­ti­a­tions, the planned purchase or sale of marketing autho­ri­sa­tions and funding rounds with venture capital investors. In doing so, you receive a vulner­a­bility analysis of the docu­ments on active substances and the finished product and a regu­la­tory and strategic appraisal, taking into account the targets you specify.

Scien­tific infor­ma­tion and adver­tising materials

Your scien­tific infor­ma­tion mate­rial needs to be sound. Does it corre­spond to the legal regu­la­tions in all aspects? We check your specialist and direct-to-consumer adver­tising just as we do scien­tific presen­ta­tions that you provide for your opinion leaders.

We Value Your Privacy
We use cookies on our website. Some of them are essential, while others help us to improve this website and your experience.
Privacy Settings
We use these technologies to analyze how this website is being used.
Name Google Analytics, Google Tag Manager
Provider Google Ireland Limited, Gordon House, Barrow Street, Dublin 4, Ireland
Purpose Cookie by Google used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy Policy
Cookie Name _ga, _gat, _gid
Cookie Expiry 2 years
Customer Interaction
These technologies will allow you to contact us through our website, i.e. use the chat widget.
Name LiveChat
Provider LiveChat Software S.A., ul. Zwycięska 47, 53-033 Wroclaw, Poland
Purpose Communication with clients via online chat using the API of the chat service LiveChat.
Privacy Policy
Cookie Name __lc_cid, __lc_cst
Cookie Expiry 2 years
Technologies required to enable the core functionality of this website.
Name Cookie Consent
Provider Owner of this website, Imprint
Purpose Saves the visitors preferences selected in the cookie banner.
Cookie Name ws_cookie_consent
Cookie Expiry 1 year